Literature DB >> 12401526

Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+-ATPase in HeLa cells.

Antonella Muscella1, Maria Giovanna Elia, Simona Greco, Carlo Storelli, Santo Marsigliante.   

Abstract

The role of ATP on regulation of the Na(+)/K(+)-ATPase activity in the human cancerous HeLa cells was investigated. HeLa cells stimulated with increasing ATP concentrations showed a dose-dependent inhibition of the Na(+)/K(+)-ATPase activity. These effects were also obtained by UTP. ATP and UTP provoked a rise in intracellular calcium concentration ([Ca(2+)](i)) persisting for at least 4 min. The inhibitor of phospholipase C, U73122, blocked the elevation of [Ca(2+)](i) provoked by ATP/UTP. The expression of mRNA for P2Y2 and P2Y6 receptors was demonstrated by RT-PCR. ATP/UTP activated PKC-alpha, -betaI and -epsilon isoforms, but not PKC-delta and -zeta. The inhibition of the Na(+)/K(+)-ATPase activity by ATP/UTP was blocked by Gö6976, a specific inhibitor of the calcium-dependent PKCs. In conclusion, our results suggest that ATP/UTP modulate Na(+)/K(+)-ATPase activity in HeLa cells through the P2Y2 purinoceptor via calcium mobilisation and activation of calcium-dependent PKCs. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12401526     DOI: 10.1016/s0898-6568(02)00062-1

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

Review 1.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

2.  Evidence for the existence of P2Y1,2,4 receptor subtypes in HEK-293 cells: reactivation of P2Y1 receptors after repetitive agonist application.

Authors:  Wolfgang Fischer; Heike Franke; Helke Gröger-Arndt; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-16       Impact factor: 3.000

Review 3.  Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets.

Authors:  Maria Luiza Mukai Franciosi; Thiago Inácio Teixeira do Carmo; Daniela Zanini; Andréia Machado Cardoso
Journal:  Inflamm Res       Date:  2022-04-04       Impact factor: 4.575

4.  Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor.

Authors:  Edyta Gendaszewska-Darmach; Marcin Szustak
Journal:  Purinergic Signal       Date:  2016-01-08       Impact factor: 3.765

5.  AMP-activated protein kinase as regulator of P2Y(6) receptor-induced insulin secretion in mouse pancreatic β-cells.

Authors:  Ramachandran Balasubramanian; Hiroshi Maruoka; P Suresh Jayasekara; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2013-01-17       Impact factor: 5.858

Review 6.  Purinergic signaling and tumor microenvironment in cervical Cancer.

Authors:  Marta Schmidt Pfaffenzeller; Maria Luiza Mukai Franciosi; Andréia Machado Cardoso
Journal:  Purinergic Signal       Date:  2020-03-13       Impact factor: 3.765

7.  Spontaneous calcium oscillations regulate human cardiac progenitor cell growth.

Authors:  João Ferreira-Martins; Carlos Rondon-Clavo; Derin Tugal; Justin A Korn; Roberto Rizzi; Maria Elena Padin-Iruegas; Sergio Ottolenghi; Antonella De Angelis; Konrad Urbanek; Noriko Ide-Iwata; Domenico D'Amario; Toru Hosoda; Annarosa Leri; Jan Kajstura; Piero Anversa; Marcello Rota
Journal:  Circ Res       Date:  2009-09-10       Impact factor: 17.367

Review 8.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.